Table 1:

Demographics, systemic and ocular health information of the preterm infants included in the study.

Demographic information	Preterm N=85
Gestational Age (wks), mean (SD)	28 (2)
Birth Weight (gm), mean (SD)	976 (269)
Age at Imaging (wks, PMA), mean(SD)	36 (0.6)
Sex, n (%)
Male	43 (51)
Race, n (%)
African-American	38 (45)
Mixed	5 (6)
Asian	3 (3)
Caucasian	39 (46)
Ethnicity, n (%)
Hispanic	7 (8)
Non-Hispanic	78 (92)
Systemic Health, n (%)
Maternal antenatal steroids	78 (92)
Patent ductus arteriosus	38 (45)
Treatment with Indomethacin	13 (15)
Early onset sepsis	2 (2)
Late onset sepsis	11 (13)
H/O transfusion	64 (75)
Intraventricular hemorrhage	8 (9)
Periventricular leukomalacia	5 (6)
Bronchopulmonary dysplasia	11 (13)
Necrotizing enterocolitis	5 (6)
Ocular health information of the preterm infants by eyes
	OD (N=84)*	OS (N=85)	p value
ROP stage at the time of imaging, n (%)			0.29
Stage 0	47 (56)	48 (57)
Stage 1	14 (17)	15 (18)
Stage 2	22 (26)	20 (23)
Stage 3	1 (1)	2 (2)
Plus disease at the time of imaging, n (%)			0.14
None	80 (95)	80 (94)
Pre-Plus	1 (1)	4 (5)
Plus	3 (4)	1 (1)
ROP zone at the time of imaging, n (%)			0.77
I	8 (10)	9 (11)
II	57 (68)	58 (68)
III	16 (19)	15 (18)
Fully Vascularized	3 (4)	3 (3)
Maximum ROP Stage, n (%)			0.22
Stage 0	36 (43)	38 (45)
Stage 1	14 (17)	14 (16)
Stage 2	24 (28)	23 (27)
Stage 3	10 (12)	9 (11)
stage 4	0 (0)	1 (1)
ROP Treatment*, n (%)			-
Bevacizumab & laser photocoagulation	4 (5)	5 (6)
Laser photocoagulation	3 (3)	3 (3)
No Therapy	77 (92)	77 (91)

^*One eye of one infant excluded for analysis due to early treatment for ROP

^**Subsequent to current exam visit; PMA: postmenstrual age; SD: standard deviation; OD: right eye, OS: left eye